Grown Rogue International (GRUSF) Payables (2009 - 2026)
Grown Rogue International's (GRUSF) quarterly Payables came in at $2.8 million in Q1 2026, up 100.23% quarter-over-quarter from $1.4 million in Q4 2025.
Grown Rogue International (GRUSF) Payables (2009 - 2026) Analysis & Trends
Grown Rogue International's Payables history runs 18 years deep, the most recent figure standing at $2.8 million for Q1 2026.
- On a quarterly basis, Payables changed N/A year-over-year to $2.8 million in Q1 2026; TTM through Mar 2026 was $2.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.4 million, up 1008.92% from the prior year.
- Payables rose to $2.8 million in Q1 2026 per GRUSF's latest filing, from $1.4 million in the prior quarter.
- Across five years, Payables topped out at $2125.8 billion in Q3 2025 and bottomed at $123695.2 in Q4 2024.
- The 5-year median for Payables is $2.5 million (2023), against an average of $177.2 billion.
- Across the five-year window, Payables sank 97.79% in 2024 and soared 18901659.31% in 2025, its largest moves.
- Year by year, Payables stood at $464043.3 in 2022, then soared by 1107.31% to $5.6 million in 2023, then sank by 97.79% to $123695.2 in 2024, then surged by 1031.46% to $1.4 million in 2025, then soared by 100.23% to $2.8 million in 2026.
- Per Business Quant, the three latest GRUSF Payables figures stand at $2.8 million (Q1 2026), $1.4 million (Q4 2025), and $2125.8 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 731.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 8.82 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | 2.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.80 Mn |
| Dec 31, 2025 | 1.40 Mn |
| Sep 30, 2025 | 2,125.81 Bn |
| Jun 30, 2025 | 1.65 Mn |
| Dec 31, 2024 | 123,695.15 |
| Sep 30, 2024 | 11.25 Mn |
| Jun 30, 2024 | 11.43 Mn |
| Dec 31, 2023 | 5.60 Mn |
| Oct 31, 2023 | 140,248.48 |
| Apr 30, 2023 | 2.60 Mn |
| Jan 31, 2023 | 2.39 Mn |
| Oct 31, 2022 | 464,043.33 |
| Oct 31, 2021 | -234,531.65 |
| Apr 30, 2021 | 1.10 Mn |
| Jan 31, 2021 | 2.21 Mn |
| Oct 31, 2020 | 628,390.00 |
| Jul 31, 2020 | 1.72 Mn |
| Apr 30, 2020 | 1.57 Mn |
| Jan 31, 2020 | 1.63 Mn |
| Oct 31, 2019 | 1.78 Mn |